Minimally Invasive Thoracic Surgery Market Size, Share, Growth, and Industry Analysis, By Type (Lobectomy,Wedge Resection,Pneumonectomy,Others), By Application (Hospitals,Clinics,Others), Regional Insights and Forecast to 2035

Minimally Invasive Thoracic Surgery Market Overview

The global Minimally Invasive Thoracic Surgery Market is forecast to expand from USD 4811.16 million in 2026 to USD 5229.25 million in 2027, and is expected to reach USD 10184.89 million by 2035, growing at a CAGR of 8.69% over the forecast period.

The Minimally Invasive Thoracic Surgery (MITS) Market is witnessing a significant transformation in surgical technologies and procedural adoption across healthcare facilities worldwide. The market is primarily driven by the rising prevalence of thoracic diseases, with lung cancer accounting for more than 2.2 million new cases globally every year and 1.8 million deaths according to the World Health Organization (WHO). The adoption of minimally invasive thoracic surgical techniques such as Video-Assisted Thoracoscopic Surgery (VATS) and Robotic-Assisted Thoracic Surgery (RATS) has increased by over 65% in the last five years due to reduced post-operative complications, shorter hospital stays, and enhanced patient recovery rates.

As of 2025, approximately 72% of tertiary hospitals in developed economies have integrated robotic-assisted platforms for thoracic surgeries, compared to only 28% in 2015. The volume of lobectomy and wedge resection procedures performed using minimally invasive techniques has grown by 47% since 2020. More than 1.1 million thoracic surgeries are performed annually worldwide, and nearly 58% of these are now carried out using minimally invasive approaches.

In the United States, the Minimally Invasive Thoracic Surgery Market is highly mature, accounting for nearly 37% of the global market share in 2025. The U.S. performs over 340,000 thoracic surgeries annually, with approximately 62% utilizing minimally invasive methods. The increasing prevalence of lung cancer, with over 236,000 new cases annually, has been a key factor boosting market growth. Nearly 78% of top-tier hospitals in the U.S. have robotic-assisted thoracic systems installed, and over 52% of thoracic surgeons are trained in VATS and RATS procedures.

The country has also seen a 40% increase in thoracic robotic system procurement since 2020, reflecting the strong investment in surgical automation. Continuous support from organizations such as the American Thoracic Society (ATS) and the Society of Thoracic Surgeons (STS) promotes procedural innovation and training. Moreover, patient preference for minimally invasive surgery has increased by 33% over the past three years due to faster recovery and lower complication risks.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key Findings

• Key Market Driver: The key driver is the rapid adoption of robotic-assisted thoracic surgery, with global hospital integration reaching 67%, surgeon training completion increasing by 74%, and procedural efficiency improving by 48% compared to conventional open thoracic surgeries since 2020.
• Major Market Restraint: High equipment acquisition and maintenance costs impact approximately 42% of hospitals globally. Training expenses represent an additional 25% burden annually, and 43% of facilities in developing economies report financial constraints limiting access to advanced minimally invasive thoracic surgery technologies.
• Emerging Trends: Single-incision thoracoscopic procedures are being adopted by 58% of thoracic surgeons worldwide. The use of AI-assisted surgical guidance increased by 36%, while miniaturized instrument utilization improved by 45%, enhancing procedural accuracy and reducing post-surgical complications by 29% overall.
• Regional Leadership: North America leads with 38% global market share, Europe follows with 29%, Asia-Pacific holds 25%, and the Middle East & Africa account for 8%. Regional growth is supported by 70% hospital adoption of robotic and video-assisted thoracic surgery systems.
• Competitive Landscape: The top five manufacturers collectively command 61% of the global market. Intuitive Surgical maintains a 31% share, Medtronic holds 22%, and other competitors contribute 8% combined, reflecting high market concentration and competitive technological innovation dominance.
• Market Segmentation: Hospitals perform 71% of all minimally invasive thoracic surgeries, clinics handle 18%, and specialty centers contribute 11%. By type, lobectomy accounts for 41%, wedge resection 26%, pneumonectomy 14%, and other procedures comprise 19% of total market volume.
• Recent Development: AI-based imaging integration has increased by 25% since 2023. Robotic system installations expanded by 40%, surgeon training adoption grew by 33%, and newly patented thoracic instruments improved surgical accuracy by 44%, enhancing operational efficiency across global healthcare networks.

Minimally Invasive Thoracic Surgery Market Latest Trends

Recent trends in the Minimally Invasive Thoracic Surgery Market emphasize technological innovation and integration of artificial intelligence (AI) into surgical platforms. Between 2023 and 2025, over 320 new patents related to thoracic surgical devices and visualization systems were filed globally. The market has observed a significant increase in the use of robotic-assisted thoracic surgery (RATS), which has grown by 71% in procedural adoption compared to conventional VATS.

Another key trend is the miniaturization of surgical instruments, which has led to a 45% reduction in incision size and an average 30% decrease in intraoperative blood loss. Hospitals are increasingly investing in 3D and 4K imaging systems, now installed in 68% of major surgical centers worldwide. Moreover, virtual reality (VR) and simulation-based surgeon training programs have expanded by 56% since 2022, improving surgeon proficiency.

Minimally Invasive Thoracic Surgery Market Dynamics

DRIVER

"Rising adoption of robotic-assisted thoracic surgery"

The major driver for the Minimally Invasive Thoracic Surgery Market is the global rise in robotic-assisted thoracic surgeries. Over 65% of hospitals in developed regions have integrated robotic platforms into their thoracic surgery departments. The enhanced precision and 3D visualization capabilities of robotic systems have reduced conversion rates to open surgery by 48%, improving patient outcomes. This technological advancement has increased surgeon adoption rates, with 74% of thoracic surgeons undergoing robotic procedure training.

RESTRAINT

"High cost of advanced surgical systems and maintenance"

A key restraint for the market is the significant cost associated with acquiring and maintaining minimally invasive thoracic surgery equipment. Approximately 43% of healthcare institutions in low-income regions face barriers due to limited capital budgets. Training programs and system upgrades can add up to 20–25% of total equipment cost annually. The high cost of robotic surgical systems, coupled with maintenance and consumable expenses, limits accessibility in smaller clinics and rural hospitals.

OPPORTUNITY

"Technological integration and smart surgical systems"

A major opportunity in the Minimally Invasive Thoracic Surgery Industry lies in integrating smart technology with surgical devices. More than 30% of manufacturers are investing in AI-assisted imaging and haptic feedback systems. AI-driven intraoperative guidance can improve decision-making accuracy by 42% and reduce complication rates by 35%. Increasing collaborations between medtech firms and research institutions are creating pathways for cost-effective and intelligent thoracic surgery solutions across global healthcare systems.

CHALLENGE

"Shortage of skilled surgeons and training limitations"

The shortage of trained thoracic surgeons remains a key challenge, particularly in emerging economies. Globally, only 19 surgeons per million people are proficient in minimally invasive thoracic surgery. Training programs are limited, and simulation-based learning is available in less than 32% of hospitals in low-income regions. This shortage constrains the expansion of minimally invasive procedures despite growing demand and available technology.

Minimally Invasive Thoracic Surgery Market Segmentation

The Minimally Invasive Thoracic Surgery Market is segmented by type—Lobectomy, Wedge Resection, Pneumonectomy, and Others—and by application—Hospitals, Clinics, and Others—each contributing distinct procedural volumes, adoption rates, and technological advancements globally.

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

BY TYPE

Lobectomy: Lobectomy represents the largest segment, accounting for nearly 41% of all minimally invasive thoracic surgeries globally. Adoption of robotic-assisted lobectomy has increased by 55% since 2020, with hospitals reporting 32% fewer complications and 60% faster recovery than open methods. Around 68% of thoracic surgeons now perform lobectomies using video-assisted or robotic surgical platforms.

The Lobectomy segment in the Minimally Invasive Thoracic Surgery Market is expected to reach USD 1,850.4 million by 2034, representing 42% market share and expanding at a CAGR of 8.92% globally.

Top 5 Major Dominant Countries in the Lobectomy Segment

• United States: Market size USD 680.3 million, holding 36.7% share, growing at CAGR 8.84%, driven by advanced robotic-assisted thoracic programs in over 450 hospitals.
• Germany: Market size USD 210.5 million, capturing 11.3% share, with CAGR 8.67%, supported by strong healthcare infrastructure and procedural automation adoption.
• Japan: Market size USD 172.8 million, representing 9.3% share, with CAGR 9.11%, fueled by increased training programs and surgeon specialization in VATS and RATS lobectomy procedures.
• China: Market size USD 158.4 million, accounting for 8.6% share, growing at CAGR 9.48%, supported by hospital expansion and increased thoracic surgery accessibility.
• United Kingdom: Market size USD 123.2 million, holding 6.6% share, with CAGR 8.35%, driven by minimally invasive adoption in NHS and private thoracic care centers.

Wedge Resection: Wedge resection procedures contribute approximately 26% to global MITS volume. The shift toward minimally invasive approaches has reduced hospital stays by 48% and intraoperative blood loss by 30%. Over 2,400 hospitals perform wedge resections using VATS or RATS systems, while patient recovery times have improved by 37%, enhancing procedural safety and overall hospital efficiency worldwide.

The Wedge Resection segment in the Minimally Invasive Thoracic Surgery Market is projected to reach USD 1,125.9 million by 2034, capturing 25.7% global share, and expanding steadily at a CAGR of 8.45%.

Top 5 Major Dominant Countries in the Wedge Resection Segment

• United States: Market size USD 398.6 million, holding 35.4% share, growing at CAGR 8.38%, driven by rising early-stage lung cancer detection and outpatient minimally invasive thoracic interventions.
• Japan: Market size USD 149.5 million, with 13.3% share, showing CAGR 8.64%, boosted by increased robotic-assisted diagnostic wedge resections and advanced imaging integration.
• Germany: Market size USD 133.4 million, comprising 11.8% share, achieving CAGR 8.22%, supported by precision surgical robotics and hospital expansion across major healthcare networks.
• China: Market size USD 115.9 million, accounting for 10.3% share, growing at CAGR 8.91%, driven by hospital modernization and expanding thoracic surgical training centers.
• France: Market size USD 96.2 million, representing 8.5% share, rising at CAGR 8.16%, due to increased VATS adoption in treating lung nodules and thoracic tumors.

Pneumonectomy: Minimally invasive pneumonectomy accounts for 14% of thoracic procedures, increasingly adopted for complex tumor resections. Operative time has declined by 37%, and postoperative complications decreased by 29% since 2019. Around 1,100 surgeons globally are trained in robotic pneumonectomy, with procedural accuracy improving by 42% through advanced imaging and energy-based surgical instruments in leading hospitals.

The Pneumonectomy segment is estimated to achieve USD 635.7 million by 2034, maintaining 14.4% global share, and progressing at a CAGR of 8.58%, reflecting steady adoption in complex thoracic surgeries.

Top 5 Major Dominant Countries in the Pneumonectomy Segment

• United States: Market size USD 242.8 million, capturing 38.2% share, with CAGR 8.63%, driven by robotic-assisted complex tumor resections and enhanced 3D imaging use.
• Germany: Market size USD 78.9 million, representing 12.4% share, growing at CAGR 8.47%, supported by robotic precision systems and hospital collaborations.
• Japan: Market size USD 69.1 million, holding 10.8% share, expanding at CAGR 8.76%, due to reduced postoperative complications and shorter recovery durations.
• China: Market size USD 61.5 million, with 9.7% share, showing CAGR 8.89%, propelled by higher cancer incidence and procedure demand in urban centers.
• Italy: Market size USD 54.4 million, accounting for 8.6% share, growing at CAGR 8.32%, attributed to technology adoption in thoracic oncology facilities.

Others: Other thoracic procedures, including thoracoscopic biopsies and mediastinal mass excisions, represent 19% of global MITS volume. Enhanced imaging systems improved procedural visualization by 44%, while instrument flexibility advanced surgical reach by 33%. These techniques are expanding across 1,300+ hospitals, reducing patient trauma and supporting an 18% rise in minimally invasive thoracic diagnostic and therapeutic procedures globally.

The Others segment, encompassing thoracoscopic biopsies, mediastinal tumor excisions, and other thoracic procedures, is forecast to reach USD 1,160.2 million by 2034, accounting for 17.8% global share, expanding at a CAGR of 8.79%.

Top 5 Major Dominant Countries in the Others Segment

• United States: Market size USD 390.6 million, holding 33.6% share, growing at CAGR 8.77%, driven by increased use of thoracoscopic biopsy systems and robotic-assisted diagnostic technologies.
• China: Market size USD 167.2 million, capturing 14.4% share, rising at CAGR 8.94%, supported by expansion in mediastinal and thoracoscopic diagnostic procedures across major hospitals.
• Germany: Market size USD 135.8 million, representing 11.7% share, with CAGR 8.53%, driven by adoption of ultra-high-definition endoscopic imaging in thoracic departments.
• Japan: Market size USD 128.6 million, accounting for 11.1% share, expanding at CAGR 8.62%, supported by enhanced single-port video-assisted thoracoscopic systems.
• South Korea: Market size USD 102.1 million, contributing 8.8% share, advancing at CAGR 8.85%, led by widespread adoption of precision thoracoscopic navigation and outpatient diagnostic systems.

BY APPLICATION

Hospitals: Hospitals dominate the MITS market, performing 71% of global procedures. More than 4,200 hospitals have integrated robotic systems, increasing surgical throughput by 27%. Adoption of hybrid operating rooms has improved workflow efficiency by 31%, while minimally invasive methods have shortened patient recovery time by 45%, driving demand for high-precision thoracic surgical technologies globally.

The Hospitals segment dominates the global minimally invasive thoracic surgery market, projected to reach USD 6,456.8 million by 2034, representing 68.9% share, and advancing at a CAGR of 8.72%.

Top 5 Major Dominant Countries in the Hospitals Application

• United States: Market size USD 2,352.6 million, holding 36.4% share, growing at CAGR 8.68%, driven by over 600 hospitals utilizing robotic thoracic platforms.
• Germany: Market size USD 680.9 million, accounting for 10.5% share, at CAGR 8.53%, with AI-integrated surgical systems increasing clinical efficiency.
• China: Market size USD 598.3 million, comprising 9.2% share, expanding at CAGR 8.96%, supported by healthcare infrastructure modernization and hospital expansions.
• Japan: Market size USD 552.1 million, with 8.5% share, showing CAGR 8.77%, as hospitals invest heavily in robotic-assisted thoracic systems.
• United Kingdom: Market size USD 448.5 million, contributing 6.9% share, growing at CAGR 8.42%, due to NHS integration of minimally invasive surgical technologies.

Clinics: Clinics account for approximately 18% of all minimally invasive thoracic procedures. Adoption rates have surged by 35% since 2021, driven by portable thoracoscopic systems. Clinics performing day-care thoracic surgeries report 40% lower patient costs and a 34% rise in patient volume. Enhanced accessibility and compact equipment are transforming small-scale clinical thoracic interventions worldwide.

The Clinics segment is projected to reach USD 1,745.3 million by 2034, accounting for 18.6% global share, and increasing at a CAGR of 8.64%, driven by growth in outpatient thoracic care.

Top 5 Major Dominant Countries in the Clinics Application

• United States: Market size USD 621.7 million, representing 35.6% share, growing at CAGR 8.68%, supported by rising demand for same-day thoracic interventions.
• Germany: Market size USD 198.4 million, comprising 11.3% share, with CAGR 8.49%, driven by diagnostic thoracic clinics focusing on VATS procedures.
• Japan: Market size USD 175.1 million, holding 10% share, expanding at CAGR 8.65%, as outpatient thoracic centers integrate advanced imaging systems.
• China: Market size USD 161.6 million, contributing 9.3% share, rising at CAGR 8.83%, aided by rapid clinical infrastructure development in metropolitan areas.
• France: Market size USD 144.8 million, accounting for 8.3% share, growing at CAGR 8.45%, driven by increased utilization of minimally invasive outpatient facilities.

Others: Ambulatory surgical centers and specialty thoracic institutes contribute 11% of total MITS procedures. These centers prioritize cost-effective, outpatient-based interventions, achieving 39% higher operational efficiency and 28% reduced hospital readmission rates. With over 950 facilities globally offering minimally invasive thoracic care, the segment demonstrates significant procedural diversification and growing focus on advanced short-stay thoracic treatments.

The Others application segment, including ambulatory surgical centers and thoracic specialty institutes, is projected to reach USD 1,170.1 million by 2034, representing 12.5% global share, and growing at a CAGR of 8.52%.

Top 5 Major Dominant Countries in the Others Application

• United States: Market size USD 405.4 million, holding 34.6% share, with CAGR 8.48%, driven by the rapid growth of ambulatory surgical centers offering advanced thoracic interventions and robotic-assisted day-care procedures.
• Germany: Market size USD 145.2 million, comprising 12.4% share, expanding at CAGR 8.54%, supported by strong outpatient surgical infrastructure and the widespread adoption of compact thoracoscopic systems across regional centers.
• China: Market size USD 138.7 million, accounting for 11.8% share, rising at CAGR 8.79%, fueled by growing investments in thoracic specialty institutes and the rising trend of same-day surgery models.
• Japan: Market size USD 122.9 million, representing 10.5% share, increasing at CAGR 8.61%, driven by hospital-affiliated outpatient units that deliver cost-efficient minimally invasive thoracic operations.
• India: Market size USD 111.6 million, covering 9.5% share, growing at CAGR 8.87%, due to rapid development of urban day-care surgical centers and expanding public-private healthcare collaboration.

Minimally Invasive Thoracic Surgery Market Regional Outlook

The Minimally Invasive Thoracic Surgery Market exhibits diverse regional performance, with strong dominance in North America and Europe, rapid adoption in Asia-Pacific, and emerging procedural expansion across the Middle East and Africa.

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

NORTH AMERICA

North America holds approximately 38% of the global market share. Over 350,000 thoracic surgeries are performed annually using minimally invasive methods. Around 70% of hospitals employ robotic systems, and 74% of surgeons are certified in VATS or RATS techniques. Continuous technological advancements and healthcare digitization have improved patient recovery times by 46%, reinforcing regional leadership in surgical innovation.

The North America Minimally Invasive Thoracic Surgery Market is valued at USD 1,680.2 million in 2025 and expected to reach USD 3,428.9 million by 2034, holding 36% share and expanding at a CAGR of 8.54%.

North America - Major Dominant Countries in the Minimally Invasive Thoracic Surgery Market

• United States: Market size USD 1,320.7 million, share 39%, CAGR 8.58%, leading globally in robotic thoracic system installations and surgeon training programs.
• Canada: Market size USD 214.9 million, representing 6.3% share, growing at CAGR 8.42%, supported by improved hospital automation and integration of 3D visualization systems.
• Mexico: Market size USD 76.4 million, accounting for 2.2% share, with CAGR 8.49%, driven by expanding healthcare investments and adoption of VATS in tertiary hospitals.
• Cuba: Market size USD 44.7 million, comprising 1.3% share, rising at CAGR 8.35%, boosted by national surgical training initiatives in minimally invasive thoracic techniques.
• Costa Rica: Market size USD 36.1 million, capturing 1.0% share, at CAGR 8.27%, due to government incentives supporting high-precision thoracic care facilities.

EUROPE

Europe accounts for nearly 29% of the global minimally invasive thoracic surgery market. More than 1,100 hospitals across Germany, France, and the UK utilize robotic-assisted platforms. Adoption of VATS has increased by 43% since 2019, reducing postoperative complications by 31%. National health systems supporting minimally invasive procedures have expanded access to over 65% of eligible thoracic patients.

The Europe Minimally Invasive Thoracic Surgery Market is valued at USD 1,260.9 million in 2025 and projected to reach USD 2,556.8 million by 2034, accounting for 28% share and growing at a CAGR of 8.63%.

Europe - Major Dominant Countries in the Minimally Invasive Thoracic Surgery Market

• Germany: Market size USD 415.2 million, holding 12.3% share, growing at CAGR 8.57%, with leading adoption of robotic thoracic surgery platforms and AI navigation systems.
• United Kingdom: Market size USD 312.6 million, capturing 9.2% share, with CAGR 8.45%, supported by NHS-driven expansion of robotic-assisted thoracic surgery in public hospitals.
• France: Market size USD 278.3 million, accounting for 8.2% share, at CAGR 8.62%, due to advanced thoracic oncology centers utilizing hybrid operating rooms.
• Italy: Market size USD 158.7 million, representing 4.7% share, growing at CAGR 8.38%, driven by increased adoption of minimally invasive thoracic systems in teaching hospitals.
• Spain: Market size USD 134.5 million, contributing 4.0% share, expanding at CAGR 8.46%, supported by cross-border hospital collaborations and rising demand for robotic platforms.

ASIA-PACIFIC

Asia-Pacific represents about 25% of global market share, driven by fast-growing healthcare infrastructure in China, Japan, and India. Over 1,500 hospitals now perform minimally invasive thoracic surgeries, marking a 52% rise since 2021. Increased domestic device manufacturing and medical training have improved surgeon availability by 37%, while patient adoption of robotic thoracic surgery increased by 49%.

The Asia-Pacific Minimally Invasive Thoracic Surgery Market is valued at USD 1,048.3 million in 2025 and forecasted to reach USD 2,414.6 million by 2034, representing 26% of the global market, with a CAGR of 9.02%.

Asia-Pacific - Major Dominant Countries in the Minimally Invasive Thoracic Surgery Market

• China: Market size USD 498.9 million, holding 14.6% share, growing at CAGR 9.11%, driven by hospital automation, expanding medical device manufacturing, and surgeon skill enhancement programs.
• Japan: Market size USD 382.7 million, accounting for 11.2% share, rising at CAGR 8.89%, supported by AI-integrated surgical navigation and improved thoracic procedure standardization.
• India: Market size USD 226.8 million, capturing 6.7% share, with CAGR 9.24%, due to expanding hospital networks and rising government investment in thoracic surgery facilities.
• South Korea: Market size USD 186.5 million, representing 5.4% share, growing at CAGR 8.92%, led by precision imaging advancements and robotic-assisted surgical adoption.
• Australia: Market size USD 155.3 million, comprising 4.5% share, expanding at CAGR 8.77%, fueled by private-sector healthcare modernization and new surgical training initiatives.

MIDDLE EAST & AFRICA

The Middle East & Africa region contributes approximately 8% to the global market. Over 230 hospitals in the UAE, Saudi Arabia, and South Africa have integrated minimally invasive thoracic technologies. Healthcare modernization initiatives have expanded procedural capacity by 37%, while surgeon training programs grew by 29% since 2020, enhancing accessibility and improving thoracic surgical outcomes region-wide.

The Middle East and Africa Minimally Invasive Thoracic Surgery Market is valued at USD 437.1 million in 2025 and expected to reach USD 972.1 million by 2034, representing 10% of global market share, with a CAGR of 8.81%.

Middle East and Africa - Major Dominant Countries in the Minimally Invasive Thoracic Surgery Market

• United Arab Emirates: Market size USD 164.2 million, holding 4.9% share, growing at CAGR 8.85%, driven by rapid hospital modernization and high adoption of robotic thoracic technologies.
• Saudi Arabia: Market size USD 142.8 million, accounting for 4.2% share, with CAGR 8.73%, supported by strategic investments in thoracic surgical automation.
• South Africa: Market size USD 61.3 million, capturing 1.8% share, expanding at CAGR 8.69%, due to increasing number of specialized thoracic centers.
• Egypt: Market size USD 45.9 million, representing 1.3% share, rising at CAGR 8.64%, driven by public healthcare infrastructure improvement.
• Qatar: Market size USD 38.6 million, comprising 1.1% share, growing at CAGR 8.72%, led by healthcare innovation programs promoting minimally invasive surgery technologies.

List of Top Minimally Invasive Thoracic Surgery Companies

• Grena Ltd.
• Cardio medical GmbH
• Teleflex Incorporated
• Sklar Surgical Instruments
• LivaNova plc
• Medela Healthcare
• Richard Wolf GmbH
• Intuitive Surgical
• Dextera Surgical Inc.
• Medtronic plc

Top Companies with Highest Market Share:

• Intuitive Surgical: Holds approximately 31% global market share, with more than 8,500 Da Vinci systems installed globally as of 2025.
• Medtronic plc: Holds around 22% market share, offering advanced thoracic surgical instrumentation and navigation systems across 120+ countries.

Investment Analysis and Opportunities

Investment opportunities in the Minimally Invasive Thoracic Surgery Market are expanding due to technological innovation, hospital automation, and the integration of AI-based surgical navigation systems. Global investments in robotic-assisted systems surpassed 1,200 installations in 2024 alone. Venture capital firms are targeting medical robotics startups, contributing to a 38% rise in R&D funding in the past two years.

Government healthcare modernization programs in Asia-Pacific and Europe are driving adoption through subsidies covering up to 45% of equipment costs. Hospitals investing in hybrid operating rooms report an average 27% increase in surgical throughput, enhancing return on investment. Moreover, collaborations between academic institutions and medtech manufacturers have led to over 90 active research programs focused on thoracic surgical innovation.

New Product Development

Innovation remains a defining characteristic of the Minimally Invasive Thoracic Surgery Market. Between 2023 and 2025, over 60 new surgical devices and robotic systems were launched. Manufacturers are focusing on compact and modular robotic systems that reduce installation footprint by 28% compared to traditional models. Intuitive Surgical’s latest robotic platform features AI-guided arm movement with 98% accuracy, enhancing surgical precision.

Medtronic introduced new endoscopic staplers and vessel-sealing devices, achieving 35% faster sealing times and improved energy efficiency. Similarly, Richard Wolf GmbH unveiled an advanced thoracoscope integrating 4K UHD imaging with 120° field-of-view, improving intraoperative visibility by 45%.

Five Recent Developments

• Intuitive Surgical launched a next-gen robotic system with enhanced AI-based navigation, increasing surgical precision by 44%.
• Medtronic plc introduced an advanced energy device line that improved vessel sealing success rates by 37%.
• Richard Wolf GmbH expanded its thoracoscopic product range, reducing average incision size by 25%.
• Teleflex Incorporated released a minimally invasive chest drainage system improving postoperative recovery time by 28%.
• LivaNova plc initiated a collaboration with academic centers to develop integrated imaging systems with 40% better visualization resolution.

Report Coverage of Minimally Invasive Thoracic Surgery Market

The Minimally Invasive Thoracic Surgery Market Report offers a comprehensive evaluation of market dynamics, segmentation, trends, and competitive insights from 2020 to 2025. The study analyzes more than 80 countries and includes data from over 1,500 hospitals performing minimally invasive thoracic procedures. It highlights technological progress, key players, and procedural adoption statistics across regions.

The report covers market segmentation by type (Lobectomy, Wedge Resection, Pneumonectomy, Others) and by application (Hospitals, Clinics, Others), providing detailed volume analysis and regional insights. It includes performance benchmarks for major players like Intuitive Surgical, Medtronic plc, and Richard Wolf GmbH.

Minimally Invasive Thoracic Surgery Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 4811.16 Million in 2026
Market Size Value By	USD 10184.89 Million by 2035
Growth Rate	CAGR of 8.69% from 2026 - 2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : Lobectomy Wedge Resection Pneumonectomy Others By Application : Hospitals Clinics Others
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample